Every recall we track for ANI Pharmaceuticals, Inc. — 13 in all — plus the complaints and injury reports the public filed about them.
ANI Pharmaceuticals recalls 10 mg/5 mL hydrOXYzine Hydrochloride Oral Solution (1 pint) due to foreign substance presence. Rx only product distributed by ANI Pharmaceuticals, Inc. in Baudette, MN. NDC: 70954-912-10, Lot S25133A.
ANI Pharmaceuticals recalls Estradiol Gel 0.1% (0.25 mg per packet) due to defective containers that may be empty or partially full. This prescription-only product was distributed with NDC 70954-531-2: Lot M251109, exp Nov 2027.
ANI Pharmaceuticals recalls 1.0 mg Alprazolam tablets from specific bottle counts and lot numbers due to cGMP deviations. These prescription-only tablets may not meet quality standards.
ANI Pharmaceuticals recalls 2mg Alprazolam tablets due to cGMP deviations in manufacturing. Products sold in 100-count and 500-count bottles with specific lot numbers and expiration dates.
ANI Pharmaceuticals recalls 500mg Pyrazinamide Tablets due to cGMP deviations. This affects Rx-only bottles manufactured by ULTRAtab Laboratories in Highland, NY. No specific remedy is listed in the recall notice.
ANI Pharmaceuticals recalls 0.25mg alprazolam tablets from specific bottle counts and lots due to cGMP deviations. These prescription-only medications may not meet quality standards.
ANI Pharmaceuticals recalls 0.5mg Alprazolam tablets with specific NDC codes and expiration dates due to cGMP deviations. Affected products may not meet quality standards.
